Getting Help > Clinical Trials > Maryland

Treatment of Childhood Social Phobia Study
Maryland Center for Anxiety Disorders, University of Maryland, College Park

Principal Investigators: Deborah C. Beidel, PhD, ABPP, professor of psychology and co-director of the Maryland Center for Anxiety Disorders, University of Maryland.

Samuel M. Turner, PhD, ABPP, professor of clinical psychology and co-director of the Maryland Center for Anxiety Disorders, University of Maryland

F. Randall Sallee, MD, PhD, Cincinnati Children's Medical Center

Description of Study: The purpose of this study is to evaluate the individual and comparative efficacy of two treatments for youth with social phobia; the behavioral treatment entitled Social Effectiveness Training for Children (SET-C) and the drug, fluoxetine. The study is designed to do the following: (a) further evaluate the efficacy of SET-C (a multimodal behavioral treatment) across an expanded age range of children and adolescents with social phobia; (b) determine the efficacy of fluoxetine for youth with social phobia, comparing it to a pill placebo control and the SET-C program; and (c) determine the long term (1year) durability of both SET-C and fluoxetine.

Eligibility Criteria:
Children must be within the age range of 8-15. Participants must meet the DSM-IV criteria for social phobia, and social phobia must be the primary disorder if more that one disorder is present. Exclusion criteria are: psychosis, autism, substance dependence, and conduct disorder.

Contact: Maryland Center for Anxiety Disorders, Department of Psychology, University of Maryland, (301) 405-0232